Handb Exp Pharmacol. 2013;218:409-436.
Emerging Molecular Targets for Anti-proliferative Strategies in Pulmonary Arterial Hypertension.
Tu L, Guignabert C.
Emerging Molecular Targets for Anti-proliferative Strategies in Pulmonary Arterial Hypertension.
Tu L, Guignabert C.
PLoS One. 2013 Oct 15;8(10):e77073. doi: 10.1371/journal.pone.0077073.
The beneficial effect of suramin on monocrotaline-induced pulmonary hypertension in rats.
Izikki M, Mercier O, Lecerf F, Lubert Guin L, Hoang E, Dorfmüller P, Perros F, Humbert M, Simonneau G, Dartevelle P, Fadel E, Eddahibi S.
The beneficial effect of suramin on monocrotaline-induced pulmonary hypertension in rats.
Izikki M, Mercier O, Lecerf F, Lubert Guin L, Hoang E, Dorfmüller P, Perros F, Humbert M, Simonneau G, Dartevelle P, Fadel E, Eddahibi S.
J Heart Lung Transplant. 2013 Oct 25. pii: S1053-2498(13)01507-6. doi: 10.1016/j.healun.2013.10.026. [Epub ahead of print]
Right ventricular plasticity in a porcine model of chronic pressure overload.
Guihaire J, Haddad F, Boulate D, Capderou A, Decante B, Flécher E, Eddahibi S, Dorfmüller P, Hervé P, Humbert M, Verhoye JP, Dartevelle P, Mercier O, Fadel E.
Right ventricular plasticity in a porcine model of chronic pressure overload.
Guihaire J, Haddad F, Boulate D, Capderou A, Decante B, Flécher E, Eddahibi S, Dorfmüller P, Hervé P, Humbert M, Verhoye JP, Dartevelle P, Mercier O, Fadel E.
Eur Respir Rev. 2013 Dec 1;22(130):543-51. doi: 10.1183/09059180.00007513.
Pathogenesis of pulmonary arterial hypertension: lessons from cancer.
Guignabert C, Tu L, Le Hiress M, Ricard N, Sattler C, Seferian A, Huertas A, Humbert M, Montani D.
Pathogenesis of pulmonary arterial hypertension: lessons from cancer.
Guignabert C, Tu L, Le Hiress M, Ricard N, Sattler C, Seferian A, Huertas A, Humbert M, Montani D.